{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:10Z","timestamp":1793235010370,"version":"4.5.0"},"reference-count":28,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>APO866 inhibits nicotinamide phosphoribosyltransferase (NMPRTase), a key enzyme involved in nicotinamide adenine dinucleotide (NAD) biosynthesis from the natural precursor nicotinamide. Intracellular NAD is essential for cell survival, and NAD depletion resulting from APO866 treatment elicits tumor cell death. Here, we determine the in vitro and in vivo sensitivities of hematologic cancer cells to APO866 using a panel of cell lines (n = 45) and primary cells (n = 32). Most cancer cells (acute myeloid leukemia [AML], acute lymphoblastic leukemia [ALL], mantle cell lymphoma [MCL], chronic lymphocytic leukemia [CLL], and T-cell lymphoma), but not normal hematopoietic progenitor cells, were sensitive to low concentrations of APO866 as measured in cytotoxicity and clonogenic assays. Treatment with APO866 decreased intracellular NAD and adenosine triphosphate (ATP) at 24 hours and 48 to72 hours, respectively. The NAD depletion led to cell death. At 96 hours, APO866-mediated cell death occurred in a caspase-independent mode, and was associated with mitochondrial dysfunction and autophagy. Further, in vivo administration of APO866 as a single agent prevented and abrogated tumor growth in animal models of human AML, lymphoblastic lymphoma, and leukemia without significant toxicity to the animals. The results support the potential of APO866 for treating hematologic malignancies.<\/jats:p>","DOI":"10.1182\/blood-2008-08-173369","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T04:50:45Z","timestamp":1233982245000},"page":"3276-3286","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":167,"title":["The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies"],"prefix":"10.1182","volume":"113","author":[{"given":"Aimable","family":"Nahimana","sequence":"first","affiliation":[{"name":"Service of Hematology, University Hospital of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Attinger","sequence":"additional","affiliation":[{"name":"TopoTarget Switzerland, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Aubry","sequence":"additional","affiliation":[{"name":"Service of Hematology, University Hospital of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Greaney","sequence":"additional","affiliation":[{"name":"TopoTarget Switzerland, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ireson","sequence":"additional","affiliation":[{"name":"TopoTarget Switzerland, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemette V.","family":"Thougaard","sequence":"additional","affiliation":[{"name":"TopoTarget Denmark, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Tj\u00f8rnelund","sequence":"additional","affiliation":[{"name":"TopoTarget Denmark, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Dawson","sequence":"additional","affiliation":[{"name":"TopoTarget Switzerland, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dupuis","sequence":"additional","affiliation":[{"name":"TopoTarget Switzerland, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel A.","family":"Duchosal","sequence":"additional","affiliation":[{"name":"Service of Hematology, University Hospital of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713482348300_B1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1046\/j.1432-1327.2000.01187.x","article-title":"New functions of a long-known molecule: emerging roles of NAD in cellular signaling.","volume":"267","author":"Ziegler","year":"2000","journal-title":"Eur J Biochem"},{"key":"2019111713482348300_B2","first-page":"1","article-title":"Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade.","volume":"9","author":"Martin","year":"1997","journal-title":"Oncol Res"},{"key":"2019111713482348300_B3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/oxfordjournals.jbchem.a022775","article-title":"Depletion of intracellular NAD(+) and ATP levels during ricin-induced apoptosis through the specific ribosomal inactivation results in the cytolysis of U937 cells.","volume":"128","author":"Komatsu","year":"2000","journal-title":"J Biochem"},{"key":"2019111713482348300_B4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-4899-1819-2_43","article-title":"DNA-damage and NAD(+)-depletion are initial events in oxygen radical induced islet cell death.","volume":"426","author":"Heller","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"2019111713482348300_B5","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/bi00368a014","article-title":"Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065.","volume":"25","author":"Jacobson","year":"1986","journal-title":"Biochemistry"},{"key":"2019111713482348300_B6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-291X(86)80388-6","article-title":"Poly(ADP-ribose) biosynthesis and suicidal NAD+ depletion following carcinogen exposure of mammalian cells.","volume":"138","author":"Alvarez-Gonzalez","year":"1986","journal-title":"Biochem Biophys Res Comm"},{"key":"2019111713482348300_B7","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1074\/jbc.M313329200","article-title":"Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition.","volume":"279","author":"Alano","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111713482348300_B8","doi-asserted-by":"crossref","first-page":"18426","DOI":"10.1074\/jbc.M301295200","article-title":"Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress.","volume":"278","author":"Du","year":"2003","journal-title":"J Biol Chem"},{"key":"2019111713482348300_B9","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res"},{"key":"2019111713482348300_B10","first-page":"1057","article-title":"WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.","volume":"62","author":"Wosikowski","year":"2002","journal-title":"Cancer Res"},{"key":"2019111713482348300_B11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(99)01578-1","article-title":"A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization.","volume":"463","author":"Hufton","year":"1999","journal-title":"FEBS Lett"},{"key":"2019111713482348300_B12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ijc.10584","article-title":"Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer.","volume":"101","author":"Van","year":"2002","journal-title":"Int J Cancer"},{"key":"2019111713482348300_B13","first-page":"313","article-title":"Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.","volume":"11","author":"Pogrebniak","year":"2006","journal-title":"Eur J Med Res"},{"key":"2019111713482348300_B14","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1074\/jbc.M706204200","article-title":"Characterization of NAD uptake in mammalian cells.","volume":"283","author":"Billington","year":"2008","journal-title":"J Biol Chem"},{"key":"2019111713482348300_B15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/auto.5635","article-title":"NAD depletion by FK866 induces autophagy.","volume":"4","author":"Billington","year":"2008","journal-title":"Autophagy"},{"key":"2019111713482348300_B16","first-page":"4853","article-title":"Antiangiogenic potency of FK866\/K22. 175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma.","volume":"23","author":"Drevs","year":"2003","journal-title":"Anticancer Res"},{"key":"2019111713482348300_B17","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1158\/1078-0432.CCR-04-1399","article-title":"Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.","volume":"11","author":"Muruganandham","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111713482348300_B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","article-title":"The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor.","volume":"26","author":"Holen","year":"2008","journal-title":"Invest New Drugs"},{"key":"2019111713482348300_B19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0002-9440(10)65463-6","article-title":"Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt lymphomas.","volume":"155","author":"Basso","year":"1999","journal-title":"Am J Pathol"},{"key":"2019111713482348300_B20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/stem.5530150826","article-title":"Assay of human stem cells by repopulation of NOD\/SCID mice.","volume":"15","author":"Dick","year":"1997","journal-title":"Stem Cells"},{"key":"2019111713482348300_B21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.leukres.2005.08.006","article-title":"A Fas agonist induces high levels of apoptosis in haematological malignancies.","volume":"30","author":"Greaney","year":"2006","journal-title":"Leuk Res"},{"key":"2019111713482348300_B22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrm2245","article-title":"Autophagy: from phenomenology to molecular understanding in less than a decade.","volume":"8","author":"Klionsky","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019111713482348300_B23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ncb1007-1102","article-title":"Autophagosome formation: core machinery and adaptations.","volume":"9","author":"Xie","year":"2007","journal-title":"Nat Cell Biol"},{"key":"2019111713482348300_B24","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.biocel.2004.02.002","article-title":"Regulation and role of autophagy in mammalian cells.","volume":"36","author":"Meijer","year":"2004","journal-title":"Intl J Biochem Cell Biol"},{"key":"2019111713482348300_B25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1247\/csf.23.33","article-title":"Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.","volume":"23","author":"Yamamoto","year":"1998","journal-title":"Cell Struct Funct"},{"key":"2019111713482348300_B26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nsmb1105","article-title":"Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents.","volume":"13","author":"Khan","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"2019111713482348300_B27","doi-asserted-by":"crossref","first-page":"e2267","DOI":"10.1371\/journal.pone.0002267","article-title":"Pharmacological inhibition of nicotinamide phosphoribosyltransferase\/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.","volume":"3","author":"Busso","year":"2008","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"2019111713482348300_B28","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.181.7.4685","article-title":"Nicotinamide phosphoribosyl transferase\/pre-B cell colony-enhancing factor\/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress.","volume":"181","author":"Rongvaux","year":"2008","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3276\/1306013\/zh801409003276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3276\/1306013\/zh801409003276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T18:48:42Z","timestamp":1574016522000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/14\/3276\/24861\/The-NAD-biosynthesis-inhibitor-APO866-has-potent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,2]]},"references-count":28,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,4,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-08-173369","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,2]]}}}